A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

Clicks: 412
ID: 114854
1991
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In infants who require mechanical ventilation because of severe respiratory syncytial virus infection, treatment with aerosolized ribavirin decreases the duration of mechanical ventilation, oxygen treatment, and the hospital stay.
Reference Key
dw1991thea Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Smith DW;Frankel LR;Mathers LH;Tang AT;Ariagno RL;Prober CG;;
Journal The New England journal of medicine
Year 1991
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/1904551
Keywords
respiration National Center for Biotechnology Information NCBI NLM MEDLINE Mechanical humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't female male Infant newborn P.H.S. Clinical Trial Randomized Controlled Trial Double-Blind Method length of stay hospitalization / economics c g prober aerosols ribavirin / administration & dosage* respiratory syncytial viruses* ribavirin / therapeutic use respirovirus infections / therapy* respirovirus infections / drug therapy pmid:1904551 doi:10.1056/nejm199107043250105 d w smith l r frankel carbon dioxide / blood oxygen / blood partial pressure artificial* ventilators

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.